Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
P-glycoprotein (P-gp) is a trans-membrane drug efflux pump. Several drugs are P-gp substrates. Some drugs may affect the activity of P-gp by inhibiting its function, resulting in significant drug-drug interactions (DDIs). It is critical to understand which drugs are inhibitors of P-gp so that advers...
Wedi'i Gadw mewn:
Prif Awduron: | Mehran Mesgari Abbasi (Awdur), Hadi Valizadeh (Awdur), Hamed Hamishehkar (Awdur), Parvin Zakeri-Milani (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Wolters Kluwer Medknow Publications,
2016-01-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
In vitro and in situ effects of atorvastatin and ezetimibe on P-glycoprotein expression and function
gan: Mehran Mesgari Abbasi, et al.
Cyhoeddwyd: (2016) -
The Effects of Cetirizine on P-glycoprotein Expression and Function In vitro and In situ
gan: Mehran Mesgari Abbasi, et al.
Cyhoeddwyd: (2016) -
Multivariate Chemometric Assisted Analysis of Metformin Hydrochloride, Gliclazide and Pioglitazone Hydrochloride in Bulk Drug and Dosage Forms
gan: Vipin Saini, et al.
Cyhoeddwyd: (2013) -
Effects of polyethylene glycols on intestinal efflux pump expression and activity in Caco-2 cells
gan: Darya Hodaei, et al.
Cyhoeddwyd: (2015) -
Valsartan in combination with metformin and gliclazide in diabetic rat model using developed RP-HPLC method
gan: Rasmita Patra, et al.
Cyhoeddwyd: (2021)